At the 5 Burning Questions event during ESCRS 2025, glaucoma specialists, including Dr. Ike Ahmed, Dr. Larissa Camejo, Dr. Morgan Micheletti, Dr. I. Paul Singh, Prof. Henny Beckers and Ms. Neeru Amrita Vallabh, tackle the assumption that prescribing drops is the “easy” choice. They discuss the long-term burden of medications, from decades of surface toxicity and side effects to the reality of inconsistent adherence in asymptomatic patients.
The discussion reframes canaloplasty with iTrack™ Advance as a tissue-sparing, system-wide outflow procedure that fits an interventional glaucoma mindset. From starting earlier in the disease course to preserving the trabecular meshwork and “saving space” for future options, the panel explores why benign-looking drops are not always the gentlest option and how believing in the value of MIGS is the first step to offering it confidently.
Visit https://itrack-advance.com/ for more information.
This content is intended exclusively for healthcare professionals and eye care practitioners. It is not intended for the general public. Products or therapies discussed may not be registered or approved in all jurisdictions, including Singapore.
